Research and Markets: Critical Outcome Technologies Inc. Product Pipeline Review 2015 - Analysis & Technologies

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/8j74jv/critical_outcome) has announced the addition of the "Critical Outcome Technologies Inc. - Product Pipeline Review - 2015" company profile to their offering.

This report provides comprehensive information on the current therapeutic developmental pipeline of Critical Outcome Technologies Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  • The report provides brief overview of Critical Outcome Technologies Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Critical Outcome Technologies Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects

Benefits of this Report:

  • Evaluate Critical Outcome Technologies Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Critical Outcome Technologies Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Critical Outcome Technologies Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Critical Outcome Technologies Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Critical Outcome Technologies Inc.

For more information visit http://www.researchandmarkets.com/research/8j74jv/critical_outcome

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Company Reports

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Company Reports